Chemotherapy of experimental allergic encephalomyelitis (EAE).
D000493:Allopurinol / Q000627:therapeutic use; D000614:Aminocaproates / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001835:Body Weight / Q000187:drug effects; D002738:Chloroquine / Q000627:therapeutic use; D003078:Colchicine / Q000627:therapeutic use; D003348:Cortisone / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003533:Cyproheptadine / Q000627:therapeutic use; D003981:Diazoxide / Q000627:therapeutic use; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D006854:Hydrocortisone / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008750:Methyldopa / Q000627:therapeutic use; D009526:Nialamide / Q000627:therapeutic use; D009821:Oils / Q000627:therapeutic use; D009929:Organ Size; D051381:Rats; D013331:Strychnine / Q000627:therapeutic use; D013627:Talc / Q000627:therapeutic use; D013792:Thalidomide / Q000627:therapeutic use; D013866:Thioguanine / Q000627:therapeutic use; D013870:Thiomalates / Q000627:therapeutic use
D000614:Aminocaproates; D000700:Analgesics; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D009821:Oils; D013870:Thiomalates; D013627:Talc; D003533:Cyproheptadine; D013792:Thalidomide; D008750:Methyldopa; D000493:Allopurinol; D002738:Chloroquine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D013866:Thioguanine; D013331:Strychnine; D001379:Azathioprine; D003981:Diazoxide; D003078:Colchicine; D009526:Nialamide; D003348:Cortisone; D006854:Hydrocortisone; D008727:Methotrexate; D004121:Dimethyl Sulfoxide